CPH 0.00% 0.9¢ creso pharma limited

Ann: Technological Breakthrough for Human Health Products, page-42

  1. 2,357 Posts.
    lightbulb Created with Sketch. 203
    It's obvious they need cash so what are you saying? No cap raise and dilute at a lower price when it's back to 1c? Raise funds via dilutive CNs? How is that of any benefit to anyone other than Everblu?

    Up to management now to show they can reduce cash burn and have a cash generative business now.


 
watchlist Created with Sketch. Add CPH (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.